Valuation : Maravai LifeSciences Holdings, Inc.

Market Cap 1.09B 938M 883M 807M 1.51B 103B 1.51B 10.43B 4.05B 52.83B 4.1B 4.01B 170B P/E 2026 *
-23.8x
P/E 2027 * -30.8x
Enterprise Value 1.14B 980M 922M 843M 1.58B 108B 1.58B 10.9B 4.23B 55.19B 4.28B 4.19B 178B EV / Sales 2026 *
5.39x
EV / Sales 2027 * 4.83x
Free-Float
45.44%
Yield 2026 *
-
Yield 2027 * -
1 day-0.68%
1 week-4.69%
Current month-4.19%
1 month+17.12%
3 months+45.82%
6 months+106.20%
Current year+125.23%
1 week 7.17
Extreme 7.17
7.6
1 month 5.53
Extreme 5.53
9.42
Current year 2.8
Extreme 2.8
9.42
1 year 2.42
Extreme 2.42
9.42
3 years 1.66
Extreme 1.665
11.56
5 years 1.66
Extreme 1.665
58
10 years 1.66
Extreme 1.665
63.55
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-07
Director of Finance/CFO 59 2025-06-29
Chief Operating Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 50 2016-02-29
Director/Board Member 65 2020-10-31
Director/Board Member 61 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/31/26 Tax

Chief Financial Officer

-5,465 0.0037%
8/10/26 Tax

Chief Executive Officer

-29,250 0.0198%
7/30/26 Tax

Chief Financial Officer

-5,465 0.0037%
Change 5-day change 1-year change 3-year change Capi.($)
-0.68%-4.69%+191.63%-32.53% 1.09B
+1.03%+9.74%+253.01%+46.74% 3.98B
-1.18%-3.61%+88.95%+269.56% 3.87B
-4.79%-1.87%+31.14%+63.51% 3.42B
+2.05%+2.19%+268.16%+477.53% 2.63B
-1.65%-6.73%-27.81%-30.97% 2.11B
-3.49%+10.28%+54.60% - 1.75B
+1.11%-10.52%+23.40%+41.78% 1.08B
-1.55%-11.92%+2.47%+33.29% 609M
+0.33%-4.13%-33.17%-5.40% 527M
Average -0.88%-0.77%+85.24%+95.94% 2.11B
Weighted average by Cap. -1.01%+0.71%+114.83%+138.01%

Financials

2026 *2027 *
Net sales 212M 182M 171M 156M 293M 19.98B 294M 2.02B 785M 10.25B 795M 777M 33.02B 226M 194M 183M 167M 312M 21.31B 313M 2.16B 838M 10.93B 848M 829M 35.23B
Net income -48.85M -42.04M -39.55M -36.13M -67.59M -4.61B -67.77M -467M -181M -2.37B -183M -179M -7.62B -33.6M -28.91M -27.2M -24.85M -46.48M -3.17B -46.61M -321M -125M -1.63B -126M -123M -5.24B
Net Debt 48.8M 41.99M 39.51M 36.09M 67.52M 4.61B 67.7M 467M 181M 2.36B 183M 179M 7.62B -385K -332K -312K -285K -533K -36.37M -534K -3.69M -1.43M -18.66M -1.45M -1.42M -60.12M
Logo Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.
Employees
415
Date Price Change Volume
26-09-04 US$7.320 -0.68% 1,552,057
26-09-03 US$7.370 -0.14% 2,907,996
26-09-02 US$7.380 +1.10% 3,668,981
26-09-01 US$7.300 -4.45% 2,698,378
26-08-31 US$7.640 -0.52% 5,318,132
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
7.320USD
Average target price
7.300USD
Spread / Average Target
-0.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MRVI Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!